Rise in Guillain-Barre syndrome following AstraZeneca Covid Vax: Research

A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious neurological condition Guillain-Barre syndrome (GBS), has been identified.

Related Keywords

United Kingdom ,London ,City Of ,Michael Lunn ,Pfizer ,University College London ,Astrazeneca ,Covid Vaccine Side ,Professor Michael Lunn ,Guillain Barre Syndrome Astrazeneca Vaccine Link ,Astrazeneca Covid Vaccine ,Guillain Barre Syndrome ,Covid Vaccine Side Effect ,